Drug Type Recombinant protein |
Synonyms UI-5 |
Mechanism HLA class I antigen A-24 alpha modulators, MAGEA4 modulators(Melanoma-associated antigen 4 modulators), NY-ESO-1 modulators(Cancer/testis antigen 1 modulators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization United Immunity Co. Ltd.Startup |
Active Organization- |
Inactive Organization United Immunity Co. Ltd.Startup |
Drug Highest PhaseDiscontinuedDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Head and Neck Neoplasms | Discovery | JP | United Immunity Co. Ltd.Startup | - |
Lung Cancer | Discovery | JP | United Immunity Co. Ltd.Startup | - |
Ovarian Cancer | Discovery | JP | United Immunity Co. Ltd.Startup | - |